妊娠期接受孕早期阿司匹林预防女性的血压趋势与子痫前期发生
前瞻性观察研究纳入237例因子痫前期高风险在孕早期启动每日81 mg阿司匹林的女性,29例(12.2%)发生子痫前期。子痫前期组从妊娠开始血压即较高并持续至整个孕期,孕早期舒张压>74 mmHg时子痫前期OR为6.5(95%CI 2.8-15.1;P<0.001)。
要点
- 孕早期启动阿司匹林者中子痫前期发生率为12.2%(29/237)。
- 子痫前期组平均动脉压斜率0.13×孕周+93.63,无子痫前期组0.11×孕周+82.61(P<0.005)。
- 孕早期舒张压>74 mmHg且孕中期收缩压>125 mmHg时子痫前期OR为9.4(95%CI 4.1-22.4)。
核心结论
- 从孕早期接受预防性阿司匹林治疗的女性中,发生子痫前期者从妊娠开始血压即显著且持续高于未发生者,作者认为这提示轻度血压升高可能使女性易于发生异常胎盘形成,进而与血压升高协同促发子痫前期,而阿司匹林对此仅不完全缓解。
研究设计与样本
- 前瞻性观察研究,在孕9-14周入组,为对因母体病史和双侧子宫动脉切迹判定子痫前期风险增高、于孕16周前开始每日81 mg阿司匹林者的二次分析。
- 共237例女性启动孕早期阿司匹林预防,其中29例(12.2%)发生子痫前期。
主要发现
- 孕4-41周共获得2881次系列血压测量(孕早期747次、孕中期1008次、孕晚期1126次)。
- 子痫前期组平均动脉压=(0.13×孕周)+93.63,无子痫前期组=(0.11×孕周)+82.61(P<0.005)。
- 孕早期舒张压和孕中期收缩压为子痫前期的独立危险因素(β分别为1.087和1.050;r2=0.24,P<0.0001)。
- 孕早期平均舒张压>74 mmHg时,子痫前期OR为6.5(95%CI 2.8-15.1;P<0.001),34周前子痫前期OR为14.6(95%CI 1.72-123.5;P=0.004)。
- 若同时孕中期平均收缩压>125 mmHg,子痫前期OR为9.4(95%CI 4.1-22.4;P<0.001),早发型子痫前期OR为34.6(95%CI 4.1-296.4;P=0.004)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To study women who initiated aspirin in the first trimester for high risk of pre-eclampsia, and compare blood-pressure trends throughout pregnancy between those with normal outcome and those who subsequently developed pre-eclampsia. METHODS: Women were enrolled into a prospective observational study at 9-14 weeks' gestation. This was a secondary analysis of those who started daily doses of 81 mg of aspirin before 16 weeks for increased risk of pre-eclampsia based on maternal history and bilateral uterine artery notching. Enrollment characteristics and blood-pressure measurements throughout gestation were compared between women who did and those who did not develop pre-eclampsia. RESULTS: Of the 237 women who initiated first-trimester aspirin prophylaxis, 29 (12.2%) developed pre-eclampsia. A total of 2881 serial blood-pressure measurements obtained between 4 and 41 weeks' gestation (747 in the first trimester, 1008 in the second and 1126 in the third) showed that women with pre-eclampsia started pregnancy with higher blood pressure and maintained this trend despite taking aspirin (mean arterial blood pressure in women with pre-eclampsia = (0.13 × gestational age (weeks)) + 93.63, vs (0.11 × gestational age (weeks)) + 82.61 in those without; P < 0.005). First-trimester diastolic and second-trimester systolic blood pressure were independent risk factors for pre-eclampsia (β = 1.087 and 1.050, respectively; r2 = 0.24, P < 0.0001). When average first-trimester diastolic blood pressure was >74 mmHg, the odds ratio for pre-eclampsia was 6.5 (95% CI, 2.8-15.1; P < 0.001) and that for pre-eclampsia before 34 weeks was 14.6 (95% CI, 1.72-123.5; P = 0.004). If, in addition, average second-trimester systolic blood pressure was >125 mmHg, the odds ratio for pre-eclampsia was 9.4 (95% CI, 4.1-22.4; P < 0.001) and that for early-onset disease was 34.6 (95% CI, 4.1-296.4; P = 0.004). CONCLUSION: In women treated with prophylactic aspirin from the first trimester, those who develop pre-eclampsia have significantly and sustained higher blood pressure from the onset of pregnancy compared with those who do not develop pre-eclampsia. This raises the possibility that mildly elevated blood pressure predisposes women to abnormal placentation, which then acts synergistically with elevated blood pressure to predispose such women to pre-eclampsia to a degree that is incompletely mitigated by aspirin. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Baschat AA, Dewberry D, Seravalli V, et al. Maternal blood-pressure trends throughout pregnancy and development of pre-eclampsia in women receiving first-trimester aspirin prophylaxis. Ultrasound Obstet Gynecol. 2018. PMID: 29266502. doi:10.1002/uog.18992
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。